NANOMEDICINES MARKET
THE GLOBAL NANOMEDICINE MARKET WAS VALUED AT US$ 177.1 BN IN 2019 AND IS FORECAST TO REACH A VALUE OF US$ 454.8 BN BY 2027 AT A CAGR OF 12.5% BETWEEN 2020 AND 2027. • NANOTECHNOLOGY IS A BROAD TERM FOR NANOSCALE SCIENCE, ENGINEERING, AND TECHNOLOGY THAT HAS ENORMOUS ECONOMIC AND TECHNOLOGICAL IMPLICATIONS. • ONE OF THE MOST PROMINENT AREAS OF NANOTECHNOLOGY RESEARCH IS HEALTHCARE. • NANOMEDICINE IS DEFINED AS THE USE OF MOLECULAR TOOLS AND KNOWLEDGE OF THE HUMAN BODY TO DIAGNOSE, TREAT, AND PREVENT DISEASE.
• GROWTH DRIVERS1. INCREASING PREVALENCE OF CHRONIC DISEASES 2. APPROVAL AND LAUNCH OF NEW PRODUCTS • TOP COMPANIES INVOLVED ARE- ABBOTT LABORATORIES, COMBIMATRIX CORPORATION, CLENE NANOMEDICINE, INC., CELLICS THERAPEUTICS, INC., NANOBIOTIX S.A, CELGENE CORPORATION, GE HEALTHCARE, NANOVIRICIDES, INC., JOHNSON & JOHNSON, MALLINCKRODT PLC., SIRNAOMICS INC., PRECISION NANOSYSTEMS INC., MERCK & COMPANY INC., NANOSPHERE, INC., PFIZER INC., AND SIGMA-TAU PHARMACEUTICALS INC.
GROWTH OPPORTUNITIES • THE PRESENCE OF UNMET MEDICAL NEEDS IN EMERGING ECONOMIES IS EXPECTED TO PROVIDE LUCRATIVE GROWTH OPPORTUNITIES FOR GLOBAL NANOMEDICINE MARKET PARTICIPANTS. • EMERGING AND HIGH-GROWTH MARKETS SUCH AS CHINA, BRAZIL, INDIA, EASTERN EUROPE, THE MIDDLE EAST, AND LATIN AMERICA ARE EXPECTED TO PROVIDE A PLETHORA OF OPPORTUNITIES IN THE FUTURE FOR THE NANOMEDICINE MARKET. • THIS IS BECAUSE ECONOMIC DEVELOPMENT IN THESE ECONOMIES HAS PROVIDED PATIENTS WITH INCREASED PURCHASING POWER AS A RESULT OF RISING DISPOSABLE INCOMES. • IMPROVEMENTS TO HEALTHCARE INFRASTRUCTURE WILL ALLOW FOR THE USE OF SOPHISTICATED TECHNOLOGIES WHILE ALSO MEETING THE POPULATION'S HIGH UNMET MEDICAL NEEDS. • FOR MORE DETAILS VISITHTTPS://COHERENTMARKETINSIGHTSUS.BLOGSPOT.COM/2022/08/NA NOMEDICINES-IS-USE-OF-NANOTECHNOLOGY.HTML
THANK YOU • CONTACT US• SALES OFFICE (U.S.) : COHERENT MARKET INSIGHTS PVT LTD, 1001 4TH AVE, #3200 SEATTLE, WA 98154, U.S. EMAIL- SALES@COHERENTMARKETINSIGHTS.COM PHONE- +1-206-701-6702